Keyphrases
HIV-1 Prevention
100%
Dapivirine
100%
Dapivirine Vaginal Ring
100%
Implementation Effort
66%
Generalized Estimating Equations
33%
Randomized Double-blind
33%
Placebo-controlled
33%
Young Age
33%
Two-level
33%
Phase II Trial
33%
Blood Plasma
33%
African Countries
33%
Condom Use
33%
Calendar Time
33%
Non-adherence
33%
Mode of Delivery
33%
Pre-exposure Prophylaxis (PrEP)
33%
Taking Part
33%
Primary Partner
33%
Partner Knowledge
33%
Vaginal Washing
33%
Menstrual Bleeding
33%
Long-acting Reversible Contraception
33%
Prophylaxis Methods
33%
Topical Preexposure Prophylaxis
33%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Vagina Ring
100%
Dapivirine
100%
Pre-Exposure Prophylaxis
33%
Placebo
16%
Clinical Study
16%
Menstruation
16%
Contraceptive Agent
16%
Condom Use
16%
Blood Plasma
16%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Dapivirine
100%
Bleeding
16%
Placebo
16%
Clinical Study
16%
Contraceptive Agent
16%